Actein
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Actein's ability to pathways involved in lipid disorders and carcinogenesis may make it a new agent for preventing and treating these major disorders, it has been shown to inhibit the proliferation of human breast cancer cells, by altering the activity of the ER IP3 receptor and Na, K-ATPase, inducing calcium release and modulating the NF-kB and MEK pathways.
Product Specifications
CAS Number
18642-44-9
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 100 mg/mL (147.75 mM)
Smiles
C[C@H] (C[C@] ([C@@H]1O[C@@]11C) (O[C@@H]1O) O[C@H]1C2) [C@@H]1[C@@] (C) ([C@@H] (C1) OC (C) =O) [C@]2 (C) [C@H] (CC2) [C@]1 (C1) [C@@]1 (CC1) [C@@H]2C (C) (C) [C@H]1O[C@@H] ([C@@H] ([C@H]1O) O) OC[C@H]1O
Molecular Formula
C37H56O11
Molecular Weight
676.9
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
218412-01 100 µg
NXPH1, Recombinant, Human, aa22-271, His-Tag (Neurexophilin-1 Precursor)
Sign In for Pricing
View Details 218412-02 500 µg
NXPH1, Recombinant, Human, aa22-271, His-Tag (Neurexophilin-1 Precursor)
Sign In for Pricing
View Details